Represented Yeshiva University in a joint collaboration with Montefiore Health System related to Albert Einstein College of Medicine.
Your business is about to engage in an M&A. Your tax returns have been questioned. You recently found out that your non-U.S. assets were subject to disclosure.
You need advice to guide you through the technical areas — someone who understands your business and can guide you through the process. One who speaks straight, cuts through the technical jargon and the morass of arcane tax laws, and helps you assess the risks in commercial terms to arrive at the best business decisions.
For the past 30 years, Scott Friedman has been doing precisely that. Whether it's for a hedge fund, a laboratory, an apparel manufacturer, a general aviation company, a university, or a Fortune 500 company, if it involves the tax effects of structuring an M&A or a joint venture, advising on a reorganization or a 1031 like-kind exchange, or juggling international and state tax laws to achieve tax efficiency and maximize after-tax proceeds, Scott has the industry knowledge, the technical knowhow, and the skills required to solve the problem. But tax is not the only consideration. Scott also has decades of practical experience working with corporate, commercial, and regulatory lawyers and counter parties, assessing and weighing collaboratively all the risk factors to arrive at a balanced approach that is best for you.
Fresenius purchase of Shiel Laboratory.
Sale of CHE Psychological Services to Altamount.
Tata's purchase of General Chemical.
400 Park Avenue South transfer tax ruling.